Next generation Cryoimmunostaining™ Suite revealed

Next generation Cryoimmunostaining™ coming Singapore, June 2020 – 18 months after premiering at the 2019 Medlab Asia exhibition in Singapore, X-ZELL’s game-changing Cryoimmunostaining™ Suite, comprised of the Cryofixator™ and Cryostainer™, is about to receive a...

X-ZELL part of Galen Growth’s 2020 HealthTech Cohort

X-ZELL part of Galen Growth’s 2020 HealthTech Cohort Singapore, May 2020 – X-ZELL is one of 23 start-ups selected to be part of Galen Growth’s inaugural HealthTech Cohort, an acceleration and networking initiative designed to champion healthcare innovation from across...

Essex Bio-Technology joins X-ZELL Seed+ Investment Round

Essex Bio-Technology Joins X-ZELL Seed+ Investment Round Singapore/Hong Kong, April 2020 – Rare cell detection specialist X-ZELL has entered into an investment agreement with Essex Bio-Investment, a wholly owned subsidiary of Essex Bio-Technology Ltd (“EssexBio”)....

X-ZELL featured in German life science magazine Laborjournal

X-ZELL featured in German life science magazine Laborjournal Freiburg, April 2020 – X-ZELL has been featured in the April edition of Laborjournal, one of Germany’s leading life science publications.    The extensive company profile, penned by science journalist Dr...